HIKAL234.10

Hikal Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersPANACEABIODCALSAIPARENTINDOCOSOLARAWINDLASINDSWFTLABHESTERBIOMcap ₹2,891 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,784.61,859.81,712.61,735.0
Other Income2.55.012.313.1
Total Income1,787.11,864.81,724.91,748.1
Expenses
+ Cost of Materials Consumed805.2882.6798.6810.6
+ Changes in Inventories19.5-45.3-36.9-53.1
+ Employee Benefit Expense246.5247.1270.3281.8
+ Finance Costs56.475.262.159.9
+ Depreciation & Amortisation117.6134.4163.8167.1
+ Other Expenses446.4447.0460.2463.4
Total Expenses1,691.61,741.01,718.11,729.7
EBITDA267.0328.4220.4232.3
EBIT149.4194.056.665.2
Profit
PBT before Exceptional Items95.5123.86.818.4
+ Exceptional Items0.00.0-85.1-76.2
Pretax Income95.5123.8-78.3-57.8
+ Current Tax28.430.0-2.0-2.0
+ Deferred Tax-2.53.0-27.5-22.0
Tax Expense25.933.0-29.5-24.0
Net Income69.690.8-48.8-33.8
+ Net Income — Continuing Ops69.690.8-48.8-33.8
+ Other Comprehensive Income-0.6-1.4-2.4-1.8
Total Comprehensive Income69.089.4-51.2-35.6
Per Share
Basic EPS5.647.36-3.96-2.74
Diluted EPS5.647.36-3.96-2.74
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.4-2.4-1.8
+ Items NOT to be Reclassified to P&L-0.8
+ Tax on Items NOT to be Reclassified1.93.22.5
+ Tax on Items NOT to be Reclassified — alt tag-0.2
+ Tax on Items to be Reclassified-0.5-0.8-0.7
Per Share — as-filed variants
Basic EPS — Continuing Operations5.647.36-3.960.09
Diluted EPS — Continuing Operations5.647.36-3.960.09
Basic EPS — Discontinued Operations0.000.000.00-2.83
Diluted EPS — Discontinued Operations0.000.000.00-2.83
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit959.91,022.5950.9977.5
Gross Margin %53.7954.9855.5256.34
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)95.5123.86.818.4
− Exceptional Items (reconciliation)0.00.0-85.1-76.2
Net Income Adj (tax-effected)69.690.84.210.8
EPS Adj5.647.360.340.87
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Filed Debt Equity0.000.010.010.01
Filed Dscr0.000.010.010.01
Filed Iscr0.000.040.040.04
Paid Up Equity Capital24.724.724.724.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.